BOOTHBAY FUND MANAGEMENT, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 79 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$35,000
-55.1%
10,965
-28.5%
0.00%
-87.5%
Q1 2019$78,000
-25.7%
15,333
-49.8%
0.01%
-46.7%
Q4 2018$105,000
+275.0%
30,562
+62.1%
0.02%
+36.4%
Q2 2016$28,000
+3.7%
18,8500.0%0.01%
+10.0%
Q1 2016$27,000
+28.6%
18,850
+48.8%
0.01%
+11.1%
Q4 2015$21,00012,6700.01%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders